Trial Profile
A Phase II Multicenter Randomized Study of Eltrombopag Combined With Cyclosporine and hATG Versus hATG and CsA as First Line Treatment in Pediatric Patients With Severe Acquired Aplastic Anemia
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Mar 2023
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary) ; Antithymocyte globulin; Ciclosporin
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 12 Mar 2021 Planned End Date changed from 20 Oct 2020 to 20 Oct 2022.
- 12 Mar 2021 Planned primary completion date changed from 20 Oct 2020 to 20 Oct 2022.
- 02 Oct 2019 Planned End Date changed from 20 Dec 2019 to 20 Oct 2020.